Drug pricing and competition policy: evolution or revolution? Meeting report 11 February 2013 Pages: 3 - 4
Call to consider preventability in NZ scheme to reduce medical errors Comment 11 February 2013 Pages: 4 - 4
Eptifibatide `highly cost-effective' for coronary stenting Media release 11 February 2013 Pages: 5 - 5
Early goal-directed therapy spares resources in sepsis/septic shock Clinical study 11 February 2013 Pages: 6 - 6
Irinotecan or oxaliplatin + fluorouracil for colorectal cancer Clinical study 11 February 2013 Pages: 6 - 6
Valsartan reduces heart failure hospitalisations and norepinephrine levels in patients with heart failure, Media release 11 February 2013 Pages: 6 - 6
Pharmacoeconomics news from the European Society of Cardiology meeting Meeting report 11 February 2013 Pages: 7 - 8
Cost-effective management of febrile paediatric patients Clinical study 11 February 2013 Pages: 8 - 8
Over 65% of physicians are only somewhat satisfied with current antiallergy treatments, Media release 11 February 2013 Pages: 9 - 9
Variable approach to managing paediatric patients with advanced heart failure Clinical study 11 February 2013 Pages: 9 - 9
A new condition-specific health-related quality-of-life questionnaire for use in women with anal incontinence Clinical study 11 February 2013 Pages: 10 - 10
Urgent need for education on appropriate antibacterial use Clinical study 11 February 2013 Pages: 10 - 10